2Juffermans NP,verbon A,van Deventer SJ,et al.Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis.J Infect Dis,1998,178:1839-1842.
3Guha M,Mackman N.LPS induction of gene expression in human monocytes.Cell Signal,2001,13:85-94.
4Albillos A,de-la-Hera A,Alvarez-Mon M.Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites.Lancet,2004,363:1608-1610.
5Prucha M,Herold I,Zazula R,et al.Significance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patients.Crit Care,2003,7:R154-R159.
6Blairon L,Wittebole X,Laterre PF.Lipopolysaccharidebinding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections.J Infect Dis,2003,187:287-291.
7Pardo A,Bartoli R,Lorenzo-Zunica V,et al.Effect of cisapride on intestine bacterial overgrowth and bacterial translocation in cirrhosis.Hepatology,2000,31:858-863.
8Liu Q,Duan ZP,Ha DK,et al.Synbiotic modulation of gut flora:effect on minimal hepatic encephalopathy in patients with cirrhosis.Hepatology,2004,39:1441-1449.
9Loguercio C,Federico A,Tuccillo C,et al.Beneficial effects of a probiotic VSL # 3 on parameters of liver dysfunction in chronic liver diseases.J Clin Gastroenterol,2005,39:540-543.
10Iredale JP.Cirrhosis:new research provides a basis for rational and targeted treatments.BMJ,2003,327:143-147.
